Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation

[1]  H. Hameed,et al.  Chitosan-Linseed Mucilage Polyelectrolyte Complex Nanoparticles of Methotrexate: In vitro Cytotoxic Efficacy and Toxicological Studies , 2022, Arabian Journal of Chemistry.

[2]  A. di Cerbo,et al.  Preparation and In Vitro Evaluation of Controlled-Release Matrices of Losartan Potassium Using Ethocel Grade 10 and Carbopol 934P NF as Rate-Controlling Polymers , 2022, Polymers.

[3]  S. N. Bukhari,et al.  Prunus armeniaca Gum-Alginate Polymeric Microspheres to Enhance the Bioavailability of Tramadol Hydrochloride: Formulation and Evaluation , 2022, Pharmaceutics.

[4]  S. N. Bukhari,et al.  pH Responsive Abelmoschus esculentus Mucilage and Administration of Methotrexate: In-Vitro Antitumor and In-Vivo Toxicity Evaluation , 2022, International journal of molecular sciences.

[5]  A. Alsalman,et al.  Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents , 2022, Molecules.

[6]  H. Hameed,et al.  Preparation and characterization of pH-responsive ionic crosslinked microparticles of mercaptopurine to target ulcerative colitis , 2021, Polymers and Polymer Composites.

[7]  B. Mishra,et al.  Development, optimization and evaluation of losartan potassium loaded Self Emulsifying Drug Delivery System , 2020 .

[8]  S. Pedroso‐Santana,et al.  Ionotropic gelation method in the synthesis of nanoparticles/microparticles for biomedical purposes , 2020 .

[9]  J. Moses,et al.  Cross-linked chitosan microparticles preparation by modified three fluid nozzle spray drying approach. , 2019, International journal of biological macromolecules.

[10]  S. El-Gizawy,et al.  Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and in-vitro characterization , 2019, Pharmaceutical development and technology.

[11]  M. Zubair,et al.  Mimosa pudica gum based nanoparticles development, characterization, and evaluation for their mutagenicity, cytotoxicity and antimicrobial activity , 2019, Materials Research Express.

[12]  A. Deep,et al.  Formulation and Evaluation of Nanoparticles containing Losartan Potassium  , 2019, International Journal of Pharmacy Research & Technology.

[13]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. , 2018, Giornale italiano di cardiologia.

[14]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[15]  V. Mokale,et al.  A statistical study on the development of micro particulate sustained drug delivery system for Losartan potassium by 32 factorial design approach , 2017 .

[16]  S. Bashir,et al.  COLOCASIA ESCULENTA CORMS MUCILAGE-ALGINATE MICROSPHERES OF OXCARBAZEPINE: DESIGN, OPTIMIZATION AND EVALUATION. , 2017, Acta poloniae pharmaceutica.

[17]  S. Razavi,et al.  Fabrication of basil seed gum nanoparticles as a novel oral delivery system of glutathione. , 2017, Carbohydrate polymers.

[18]  J. Reena,et al.  Design of Curcumin Loaded Polymeric Nanoparticles-Optimization, Formulation and Characterization , 2016 .

[19]  Shery Jacob,et al.  A simple practice guide for dose conversion between animals and human , 2016, Journal of basic and clinical pharmacy.

[20]  M. Ashokkumar,et al.  Process intensification of copper chromite (CuCr2O4) nanoparticle production using continuous flow microreactor , 2015 .

[21]  J. Akbari,et al.  Evaluation of Ocimum basilicum L. seed mucilage as rate controlling matrix for sustained release of propranolol HCl , 2015 .

[22]  Maria A. Azevedo,et al.  Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2. , 2014, International journal of biological macromolecules.

[23]  M. Athar,et al.  Glucoxylan-mediated green synthesis of gold and silver nanoparticles and their phyto-toxicity study. , 2014, Carbohydrate polymers.

[24]  V. Mokale,et al.  Chitosan reinforced alginate controlled release beads of losartan potassium: design, formulation and in vitro evaluation , 2014, Journal of Pharmaceutical Investigation.

[25]  M. Bozack,et al.  The synthesis and arrested oxidation of amorphous cobalt nanoparticles using DMSO as a functional solvent , 2013, Journal of Nanoparticle Research.

[26]  A. Šmelcerović,et al.  Crosslinking of polysaccharides with activated dimethylsulfoxide , 2013 .

[27]  Jency George,et al.  PHARMACOLOGY AND TRADITIONAL USES OF MIMOSA PUDICA , 2013 .

[28]  Gun-Hee Kim,et al.  Preparation, characteristics, and stability of glutathione-loaded nanoparticles. , 2011, Journal of agricultural and food chemistry.

[29]  Sumit Kumar,et al.  Microwave-assisted synthesis and characterization of polyacrylamide grafted co-polymers of Mimosa mucilage , 2011 .

[30]  Ashok Kumar,et al.  Evaluation of Mimosa pudica Seed Mucilage as Sustained-Release Excipient , 2009, AAPS PharmSciTech.

[31]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  C. S. Sipaut,et al.  Effect of the drying techniques on the morphology of silica nanoparticles synthesized via sol–gel process , 2008 .

[33]  P. Mukherjee,et al.  Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. , 2007, International journal of pharmaceutics.

[34]  V. Parcha,et al.  Studies on Ocimum gratissimum seed mucilage: evaluation of binding properties. , 2006, International journal of pharmaceutics.

[35]  J. Benoit,et al.  Preparation, purification and morphology of polymeric nanoparticles as drug carriers. , 1996, Pharmaceutica acta Helvetiae.

[36]  C. Sweet,et al.  Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. , 1995, The American journal of cardiology.

[37]  F. Abdoon,et al.  Prospective of microwave-assisted and hydrothermal synthesis of carbon quantum dots/silver nanoparticles for spectrophotometric determination of losartan potassium in pure form and pharmaceutical formulations , 2021 .

[38]  S. El-Gizawy,et al.  APPLICATION OF FACTORIAL DESIGN TO FORMULATE AND OPTIMIZE LOSARTAN POTASSIUM- LOADED SOLID LIPID NANOPARTICLES , 2020 .

[39]  A. Vladár,et al.  Characterization of nanoparticles by scanning electron microscopy , 2020 .

[40]  E. Essa,et al.  Development and evaluation of liquid oral controlled release systems for Losartan potassium , 2019, Journal of Applied Pharmaceutical Science.

[41]  Arif Luqman Rozman,et al.  Investigation of Nanoparticles Dispersion in Sodium Hydroxide (NaOH) Solvent , 2017 .

[42]  M. Ahmad,et al.  MANAGEMENT OF HYPERTENSION AMONG THE PATIENTS WITH DIABETES MELLITUS AND HEART DISEASES , 2015 .

[43]  M. Kumar,et al.  Formulation and i n vitro characterization of Carbamazepine polymeric nanoparticles with enhanced solubility and sustained release for the treatment of Epilepsy , 2015 .

[44]  H. Hameed,et al.  Chrono pharmacotherapy: A pulsatile Drug Delivery , 2015 .

[45]  J. P. Paques.  Alginate Nanospheres Prepared by Internal or External Gelation with Nanoparticles , 2015 .

[46]  Saikat Das,et al.  Formulation Development and In-Vitro Evaluation of Extended Release Tablets Containing Losartan Potassium , 2013 .

[47]  R. Piva,et al.  roduction of polymeric micelles by microfluidic technology for combined drug elivery : Application to osteogenic differentiation of human periodontal igament mesenchymal stem cells ( hPDLSCs ) , 2012 .

[48]  S. Ashish,et al.  Recent Advances In Ndds (Nov el Drug Delivery System) For Delivery Of Anti- Hypertensive Drugs , 2011 .